TY - JOUR
T1 - NCCN guidelines® insights
T2 - Genetic/Familial High-Risk Assessment: Colorectal, version 3.2017 featured updates to the NCCN Guidelines
AU - Gupta, Samir
AU - Provenzale, Dawn
AU - Regenbogen, Scott E.
AU - Hampel, Heather
AU - Slavin, Thomas P.
AU - Hall, Michael J.
AU - Llor, Xavier
AU - Chung, Daniel C.
AU - Ahnen, Dennis J.
AU - Bray, Travis
AU - Cooper, Gregory
AU - Early, Dayna S.
AU - Ford, James M.
AU - Giardiello, Francis M.
AU - Grady, William
AU - Halverson, Amy L.
AU - Hamilton, Stanley R.
AU - Klapman, Jason B.
AU - Larson, David W.
AU - Lazenby, Audrey J.
AU - Lynch, Patrick M.
AU - Markowitz, Arnold J.
AU - Mayer, Robert J.
AU - Ness, Reid M.
AU - Samadder, Niloy Jewel
AU - Shike, Moshe
AU - Sugandha, Shajanpeter
AU - Weiss, Jennifer M.
AU - Dwyer, Mary A.
AU - Ogba, Ndiya
N1 - Publisher Copyright:
© JNCCN-Journal of the National Comprehensive Cancer Network.
PY - 2017/12/1
Y1 - 2017/12/1
N2 - The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the management of patients with high-risk syndromes associated with an increased risk of colorectal cancer (CRC). The NCCN Panel for Genetic/Familial High-Risk Assessment: Colorectal meets at least annually to assess comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on genes newly associated with CRC risk on multigene panels, the associated evidence, and currently recommended management strategies.
AB - The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the management of patients with high-risk syndromes associated with an increased risk of colorectal cancer (CRC). The NCCN Panel for Genetic/Familial High-Risk Assessment: Colorectal meets at least annually to assess comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on genes newly associated with CRC risk on multigene panels, the associated evidence, and currently recommended management strategies.
UR - http://www.scopus.com/inward/record.url?scp=85038429758&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2017.0176
DO - 10.6004/jnccn.2017.0176
M3 - Review article
C2 - 29223984
AN - SCOPUS:85038429758
SN - 1540-1405
VL - 15
SP - 1465
EP - 1475
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 12
ER -